openPR Logo
Press release

Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 2019-2025

09-06-2021 12:00 PM CET | Health & Medicine

Press release from: Orion Market Reports

The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease, 120,000 with ulcerative colitis, and 15,000 with IBD type unclassified (IBD-U). CCC further estimates that seven out of every 1,000 Canadians has IBD. Moreover, by 2030, the number of people living with IBD is expected to rise to over 400,000, or nearly 1% of the population. The highest reported incidence of IBD is in Nova Scotia at 54.6 per 100,000 new cases per year, and the lowest is in British Columbia at 18.7 per 100,000 people per year. The incidence of IBD in Alberta, Manitoba, Ontario, Quebec, and Saskatchewan are similar, ranging from 21.6 to 28.3 per 100,000 people per year.

(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/canada-ibd-inflammatory-bowel-disease-market

Canada IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Canada IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/canada-ibd-inflammatory-bowel-disease-market

Market Segmentation

Canada IBD Market by Disease Type
• Ulcerative Colitis
• Crohn’s Disease

Canada IBD Market by Diagnostics
• Blood and Stool Tests
• Endoscopies,
• Ultrasound
• X-Ray

Canada IBD Market by Therapeutics
• Surgery
• Anti- Inflammatory Drug Administration
• Steroids
• Immunosuppressant
• Biological Drugs
• Amino salicylates
• Others

Company Profiles
• Abbott Laboratories
• AbbVie Inc.
• Accesa Labs
• Boehringer Ingelheim International GmbH
• Celgene Corp.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Laboratory Corporation of America Holdings

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-ibd-inflammatory-bowel-disease-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 2019-2025 here

News-ID: 2382086 • Views: 447

More Releases from Orion Market Reports

Crystal Tableware Market Is Likely to Experience a Tremendous Growth by 2028
Crystal Tableware Market Is Likely to Experience a Tremendous Growth by 2028
The Crystal Tableware Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2023-2029). Crystal tableware are made of glass and its products are available in transparent, colored and matte forms. Over the past few years, the consumers have been replacing the old- fashioned designs with the new fashionable products such as crystal tableware. Consumers are looking for affordable and less formal options,
Water-soluble Antioxidant Market to Witness Growth Acceleration by 2028
Water-soluble Antioxidant Market to Witness Growth Acceleration by 2028
The Water-soluble Antioxidant Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2023-2029). Water-soluble antioxidants are compounds that are capable of inhibiting or preventing oxidative damage in aqueous environments. They possess the ability to scavenge free radicals, which are highly reactive molecules that can cause cellular damage and contribute to various diseases. Unlike lipid-soluble antioxidants, water-soluble antioxidants have the advantage of being
One Way Bearing Market Booming Worldwide with Latest Trend and Future Scope by 2028
One Way Bearing Market Booming Worldwide with Latest Trend and Future Scope by 2 …
The One Way Bearing Market size is expected to grow at an annual average of CAGR 9% during the forecast period (2023-2029). A one-way bearing, also known as a freewheel or overrunning clutch, is a mechanical device that allows the rotation in one direction while preventing it in the opposite direction. It consists of an inner and outer race, along with a set of rollers or needles that transmit torque
Floor Spring Market to See Massive Growth by 2028
Floor Spring Market to See Massive Growth by 2028
The Floor Spring Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Floor spring is a type of door closer mechanism that is installed at the bottom of a door to control its opening and closing. It functions by creating resistance to the door's movement and ensuring controlled closing without any slam or sudden closing. Floor springs are widely used in

All 5 Releases


More Releases for IBD

Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our